StonvexLoading…
StonvexStonvexStonvexCore line items from RLI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $423.87M | $1.88B | $1.42B | $907.49M |
Operating Income | $67.34M | $505.98M | $392.39M | $235.15M |
Net Income | $54.88M | $403.34M | $312.16M | $124.34M |
EPS (Diluted) | $0.60 | $4.37 | $3.38 | $2.03 |
Total Assets | $6.40B | $6.16B | $6.25B | $5.99B |
Total Liabilities | $4.61B | $4.38B | $4.37B | $4.26B |
Cash & Equivalents | $49.12M | $51.56M | $52.62M | $21.41M |
Free Cash Flow OCF − CapEx | $41.77M | $608.70M | $453.72M | $275.88M |
Shares Outstanding | 91.93M | 91.88M | 91.84M | 91.83M |